Drugs / Vehicle Ophthalmic Solution
Drug research

Vehicle Ophthalmic Solution

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Control

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseNCT05424549ALDXPhase 2Completed2022-05-09Actual
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseNCT03404115ALDXPhase 2Completed2018-07-11Actual
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic ConjunctivitisNCT05234554ALDXPhase 3Completed2023-04-22Actual
A Clinical Trial to Assess Subjects With Dry Eye Disease.NCT04971031ALDXPhase 2Completed2021-09-08Actual
The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT05062330ALDXPhase 3Completed2022-03-04Actual
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseNCT06389214ALDXPhase 3Completed2024-06-11Actual
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisNCT03494504ALDXPhase 3Completed2018-11-05Actual
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseNCT06493604ALDXPhase 3Completed2025-02-27Actual
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry EyeNCT05201170PTNPhase 3Completed2023-09-01Actual
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.NCT04207736ALDXPhase 3Completed2021-02-16Actual

Regulatory dates and decisions

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.